Annex Advisory Services LLC Has $40.32 Million Stock Holdings in SPDR S&P Biotech ETF $XBI

Annex Advisory Services LLC boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% in the second quarter, Holdings Channel reports. The institutional investor owned 254,762 shares of the exchange traded fund’s stock after acquiring an additional 7,659 shares during the quarter. Annex Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $40,316,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Avoro Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $256,053,000. Bank of America Corp DE raised its holdings in shares of SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after acquiring an additional 1,700,851 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after acquiring an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp boosted its position in SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Finally, Morgan Stanley boosted its position in SPDR S&P Biotech ETF by 8.3% during the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $158.07 on Wednesday. The business’s 50-day moving average price is $149.09 and its two-hundred day moving average price is $135.85. SPDR S&P Biotech ETF has a one year low of $85.37 and a one year high of $165.71. The company has a market capitalization of $10.32 billion, a P/E ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.